BRIEF-Summit's agreement with Sarepta also contains a standstill provision

martes 4 de octubre de 2016 07:41 GYT
 

Oct 4 (Reuters) - Summit Therapeutics Plc :

* Collaboration agreement with Sarepta also contains a standstill provision - SEC filing

* Summit Therapeutics - Believes cash, cash equivalents, certain upfront payments from Sarepta collaboration to be sufficient to fund expenses through 2018 Source text for Eikon: Further company coverage: ;))